Detailed Narrative
Q3 FY26 Financial Performance and Margin Resilience
Cyient DLM reported Q3 FY26 revenue of INR 3,033 million, a significant 31.7% year-on-year decline, primarily attributed to the completion of a large cyclical order in FY25. Despite the revenue softness, the company demonstrated strong margin resilience, with normalized EBITDA margin expanding by 207 basis points YoY to 10.2%, reaching INR 309 million. Normalized PAT stood at INR 138 million, with its margin improving by 73 bps YoY to 4.6%, reflecting a healthy mix and operational efficiencies.
Robust Order Book and Positive Growth Outlook
The company maintained strong order momentum, securing INR 387 crores in new orders during Q3 FY26, resulting in a book-to-bill ratio of 1.3 for the quarter and 1.56 year-to-date. The total order book closed Q3 FY26 at INR 23.5 billion, marking three consecutive quarters of growth. Management expressed high confidence in achieving positive year-over-year revenue growth in Q4 FY26 and anticipates substantial growth, potentially 20-25%, in FY27, signaling that the revenue challenges are largely behind them.
Strategic Diversification and Build-to-Spec Expansion
Cyient DLM is actively diversifying its industry mix, with automotive, industrial, and medical segments showing increased traction and contributing more meaningfully to the pipeline. Two new logos were added this quarter in the medical and industrial sectors. The company is also focusing on expanding its build-to-spec (B2S) offerings, targeting growth from 6-7% of revenue in FY26 to a double-digit percentage in FY27, which is expected to be a key driver for future margin expansion alongside industry mix changes.
Working Capital Management and Tariff Mitigation
Net working capital saw a temporary increase in Q3 due to elevated DIO inventory, caused by customer-specific shipment delays. However, management expects NWC levels to normalize by the end of Q4. Addressing US tariffs, which previously imposed a 50% duty on certain shipments, the company has provided customers with four options to mitigate the impact, expecting these solutions to facilitate product shipments in Q4 and reduce the overall tariff burden.
Capital Allocation and M&A Strategy
The company remains net cash positive and possesses significant dry powder, with the ability to deploy an additional INR 350-400 crores for working capital or new capital expansions/acquisitions. During the quarter, Cyient DLM incurred a one-time📎 expense of $17.75 million for an international M&A opportunity that was pursued but ultimately abandoned due to unfavorable terms. IPO proceeds utilization stands at 93.2% for working capital and 15.4% for capex, with the remaining capex to be deployed as planned in the coming quarters⏳.